Category

Search Reports

Filters

Sub Category

Geography

Publish Date

Vietnam Anti-Rheumatic Drug Market Size, Share, Opportunities And Trends By Type of Disease (Osteoar....

Vietnam antirheumatic drugs market was valued at US$1,205.182 million in 2019. Increasing incidence of malaria is driving the demand for antirheumatic drugs in the country. Mushrooming number of people suffering from arthritis in Vietnam is another major factor that is spurring the demand for antirheumatic drugs in the country. In 2019, the University of Medical Center in Ho Chi Minh City reported the ever-increasing number of rheumatoid arthritis patients. With growing adoption of Weste Read more...

$2200 Sample Request

Bangladesh Anti-Rheumatic Drug Market Size, Share, Opportunities And Trends By Type of Disease (Oste....

Bangladesh antirheumatic drugs market was valued at US$1,953.071 million in 2019. Increasing cases of rheumatoid arthritis in Bangladesh is one of the major factors that is fuelling the market growth of antirheumatic drugs in the country. Another major driver is the prevalence of malaria in Bangladesh which is a significant public health problem in the country. Increasing burden of chronic diseases coupled with growing geriatric population is further boosting the demand for antirheumatic Read more...

$2200 Sample Request

Asia Pacific (APAC) Anti-Rheumatic Drug Market Size, Share, Opportunities And Trends By Type of Dise....

Asia Pacific (APAC) Antirheumatic Drugs market was valued at US$44,513.265 million in 2019. The rapidly growing number of patients suffering from various lifestyle-related diseases is one of the major factors behind the growth of the antirheumatic drug market in the region. There has been a continuous rise in the prevalence of diabetes in countries like China, India, and South Korea. In India, for example, according to the World Bank Group, the prevalence of diabetes among individuals ag Read more...

$2600 Sample Request

Argentina Anti-Rheumatic Drug Market Size, Share, Opportunities And Trends By Type of Disease (Osteo....

Argentine Antirheumatic Drugs market was valued at US$879.042 million in 2019. The rise in the number of patients suffering from chronic diseases including cardiovascular diseases is witnessing continuous growth in Argentina. According to the World Health Organization, the total prevalence of diabetes in Argentina is 10.2% of the country’s total population. The prevalence of these types of chronic diseases in Argentina is leading to a rise in the number of patients suffering from a Read more...

$2200 Sample Request

Canada Anti-Rheumatic Drug Market Size, Share, Opportunities And Trends By Type of Disease (Osteoart....

Canada Antirheumatic Drugs market was valued at US$684.940 million in 2019. The growing aging population in Canada is the major factor that is driving the demand for antirheumatic drugs in the country. According to Statistics Canada, there are 5.9 million Canadian senior citizens as compared to 5.8 million Canadians who are 14 and under. According to the data provided by the Government of Canada, almost one in seven Canadians was above 65 in 2012 which is projected to rise to nearly one Read more...

$2200 Sample Request

China Anti-Rheumatic Drug Market Size, Share, Opportunities And Trends By Type of Disease (Osteoarth....

China antirheumatic drugs market was valued at US$17,516.041 million in 2019. A growing number of patients suffering from arthritis in China is the major driver of the antirheumatic drugs market in the country.  According to the data from the Osteoarthritis Research Society International, its 2018 report showed that more than 8 percent of the total Chinese population is living with physician-diagnosed symptomatic knee OA while the prevalence of any type of arthritis/rheumatism was a Read more...

$2200 Sample Request

Europe Anti-Rheumatic Drug Market Size, Share, Opportunities And Trends By Type of Disease (Osteoart....

The European antirheumatic drugs market was valued at US$8,038.148 million in 2019. The antirheumatic drugs market in the European region is expected to grow substantially over the course of the next five years. The major factors that are driving the market growth throughout the region include the moderate incidence of numerous rheumatic diseases in various countries of the region. Furthermore, the presence of the state-of-art pharmaceutical industry in major countries of the European re Read more...

$2600 Sample Request

Germany Anti-Rheumatic Drug Market Size, Share, Opportunities And Trends By Type of Disease (Osteoar....

Germany antirheumatic drugs market as valued at US$1,382.401 million in 2019. The antirheumatic drug market in Germany is projected to show a nominal growth over the course of the next five years due to the growing geriatric population along with the presence of a well-established healthcare sector in the country. The booming healthcare expenditure in the country is also bolstering the anti-rheumatic drug market growth in the country throughout the forecast period. As per the data from t Read more...

$2200 Sample Request

India Anti-Rheumatic Drug Market Size, Share, Opportunities And Trends By Type of Disease (Osteoarth....

India Antirheumatic Drugs market was valued at US$15,727.680 million in 2019. Increasing the prevalence of chronic diseases such as obesity and diabetes one of the major factors that is boosting the market growth of the antirheumatic drugs market in India. According to the World Bank Group, the prevalence of diabetes among individuals aged between 20 and 79 was 10.39% in 2017. This means that number of individuals hit by diabetes was around 139.12 million which was nearly 3% more than th Read more...

$2200 Sample Request

Israel Anti-Rheumatic Drug Market Size, Share, Opportunities And Trends By Type of Disease (Osteoart....

Israel antirheumatic drugs market was valued at US$143.570 million in 2019. The market in Israel is poised to show decent growth over the course of the next five years due to rapid growth in the private healthcare spending of the country which is further anticipated to drive the demand for numerous treatments, medical services, and medicines among others. According to data by the Israel Central Bureau of Statistics, the proportion of private spending reached 40%, thus indicating a rise i Read more...

$2200 Sample Request
TOTAL RESULTS: 769

OUR CLIENTS